#news #biotech Dicerna narrows focus for kidney drug after mixed data, setting up head-to-head market battle with rival Alnylam

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Dicerna narrows focus for kidney drug after mixed data, setting up head-to-head market battle with rival Alnylam .Dicerna narrows focus for kidney drug after mixed data, setting up head-to-head market battle with rival Alnylam
badams
Tue, 10/19/2021 – 08:57

from FierceBiotech: Biotech https://ift.tt/3EatzGP